Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS

    Q301 - CLONOSEQ MEASURABLE RESIDUAL DISEASE (MRD) TESTING SERVICES

    DEPARTMENT OF VETERANS AFFAIRS
    Sol. 36C25026Q0104Award NoticeDAYTON, OH
    Closed
    STATUS
    Closed
    POSTED
    Dec 30, 2025
    Publication date
    NAICS CODE
    621511
    Primary industry classification
    PSC CODE
    Q301
    Product & service classification

    AI Summary

    The Department of Veterans Affairs has awarded a one-year firm fixed price contract to Adaptive Biotechnologies Corporation for Clono-Seq Assay testing services at the Louis Stokes VA Medical Center. For inquiries, contact Thomas Bellamy, Contracting Officer, at Thomas.Bellamy@va.gov.

    Contract details

    Solicitation No.
    36C25026Q0104
    Notice Type
    Award Notice
    Posted Date
    December 30, 2025
    Response Deadline
    NAICS Code
    621511AI guide
    PSC / Class Code
    Q301
    Primary Contact
    Thomas Bellamy
    City
    DAYTON
    State
    OH
    ZIP Code
    45428
    AI Product/Service
    service

    Description

    The Department of Veterans Affairs, Network Contracting Office 10, made an award for a one (1) year firm fixed price (FFP) contract with Adaptive Biotechnologies Corporation, 1165 Eastlake Ave. E, Seattle WA, 98109 to provide Clono-Seq Assay testing services for the Louis Stokes VA Medical Center, Pathology & Laboratory Services (PALMS), 10701 East BLVD., Cleveland, OH 44106.

    The point of contact is Thomas Bellamy, Contracting Officer, Network Contracting Office 10 - Thomas.Bellamy@va.gov.

    Key dates

    1. December 30, 2025Posted Date

    AI search tags

    Frequently asked questions

    Q301 - CLONOSEQ MEASURABLE RESIDUAL DISEASE (MRD) TESTING SERVICES is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.